| Financial Year |
March 31 2023 |
| Monetary Funds |
142,788,500.63 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
7,075,304.06 |
| Accounts Receivable |
902,413,662.32 |
| Advances to Suppliers |
249,237,443.01 |
| Other Receivables |
34,390,651.39 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
46,013.04 |
| Dividend Receivable |
-- |
| Inventories |
232,178,939.89 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
4,856,210.93 |
| Total Current Assets |
1,914,914,388.12 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
-- |
| Fixed Assetes |
228,947,581.06 |
| Under-construction Projects |
3,117,571.68 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
15,762,028.71 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
4,156,870.19 |
| Deferred Income Tax Assets |
42,498,803.30 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
332,488,044.72 |
| Total Assets |
2,247,402,432.84 |
| Short-Term Loans |
80,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
134,713,586.12 |
| Accounts Payable |
1,068,051,911.77 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
8,781,497.35 |
| Taxes Payable |
8,080,032.42 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
174,788,480.48 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
246,150.37 |
| Other Current Liabilities |
39,482,636.97 |
| Sub-Total of Current Liabilities |
1,821,705,559.12 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
865,266.13 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
6,892,478.14 |
| Total Liabilities |
1,828,598,037.26 |
| Paid-In Capital(Or Share Stock) |
227,000,000.00 |
| Capital Surplus |
358,656,856.14 |
| Surplus Reserve |
35,923,403.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-238,035,001.21 |
| Minority Stockholder's Interest |
33,744,246.41 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
385,060,149.17 |
| Owner's Equity（Stockholder's Equity） |
418,804,395.58 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,247,402,432.84 |
